Antiparkinsonian Dopamine Agonists

Antiparkinsonian dopamine agonists are a therapeutic class of medications used primarily to manage the motor symptoms of Parkinson's disease, either as initial monotherapy to delay levodopa-related motor complications or as adjunctive therapy in advanced disease In clinical practice, members of this class—divided into non-ergot and older ergot derivatives—are also widely indicated for other neurological and endocrine conditions, notably restless legs syndrome and hyperprolactinemia

Antiparkinsonian dopamine agonists are a therapeutic class of medications used primarily to manage the motor symptoms of Parkinson's disease, either as initial monotherapy to delay levodopa-related motor complications or as adjunctive therapy in advanced disease Unlike levodopa, which serves as a metabolic precursor, these agents exert their therapeutic effect by directly binding to and activating striatal dopamine receptors—predominantly within the D2-like receptor subfamily—thereby mimicking e...

Unlike levodopa, which serves as a metabolic precursor, these agents exert their therapeutic effect by directly binding to and activating striatal dopamine receptors—predominantly within the D2-like receptor subfamily—thereby mimicking endogenous dopamine signaling

Unlike levodopa, which serves as a metabolic precursor, these agents exert their therapeutic effect by directly binding to and activating striatal dopamine receptors—predominantly within the D2-like receptor subfamily—thereby mimicking endogenous dopamine signaling